They identified all-trans retinoic acid (ATRA) as an inhibitor of endogenous MYB expression, showing that it downregulates the expression of the MYB-NFIB fusion protein in ACC cells in vitro and suppresses tumor growth in ACC patient-derived xenograft models in vivo. Here, NFIB is linked to adrenal cortex carcinoma.